Previously, Abdi et al., showed that Ang2 plasma levels were associated with group A-like PfEMP1 expression and rosetting29, and that Ang2 levels were associated with development of the specific SM clinical manifestations RD and CM. This evidence concerns the gene ANGPT2 and systemic mastocytosis.